Other Species / Isoforms
  VGLL4 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S13-p
DVLSRAAsLVHADDE
0 3
VGLL4 (human) DVLSRAAsLVHADDE S13-p
VGLL4 iso2 (human) gap -
VGLL4 iso4 (human) gap -
VGLL4 (mouse) gap -
VGLL4 (rat) gap -
S43
PVASALSSHRtGPPP
0 1
VGLL4 (human) PVASALSSHRtGPPP S43
VGLL4 iso2 (human) PVASALSSHRTGPPP S12
VGLL4 iso4 (human) PVASALSsHRTGPPP S49-p
VGLL4 (mouse) PVASALSSHRtGPPP S49
VGLL4 (rat) PVASALSSHRTGPPP S49
T46-p
SALSSHRtGPPPIsP
0 10
VGLL4 (human) SALSSHRtGPPPIsP T46-p
VGLL4 iso2 (human) SALSSHRTGPPPISP T15
VGLL4 iso4 (human) SALSsHRTGPPPIsP T52
VGLL4 (mouse) SALSSHRtGPPPIsP T52-p
VGLL4 (rat) SALSSHRTGPPPIsP T52
S52-p
RtGPPPIsPsKRKFs
1 64
VGLL4 (human) RtGPPPIsPsKRKFs S52-p
VGLL4 iso2 (human) RTGPPPISPSKRKFS S21
VGLL4 iso4 (human) RTGPPPIsPSKRKFS S58-p
VGLL4 (mouse) RtGPPPIsPsKRKFs S58-p
VGLL4 (rat) RTGPPPIsPSKRKFS S58-p
S54-p
GPPPIsPsKRKFsME
0 9
VGLL4 (human) GPPPIsPsKRKFsME S54-p
VGLL4 iso2 (human) GPPPISPSKRKFSME S23
VGLL4 iso4 (human) GPPPIsPSKRKFSME S60
VGLL4 (mouse) GPPPIsPsKRKFsME S60-p
VGLL4 (rat) GPPPIsPSKRKFSLE S60
S59-p
sPsKRKFsMEPGDED
Upstream
0 42
Treatment
  • ischemia
VGLL4 (human) sPsKRKFsMEPGDED S59-p
VGLL4 iso2 (human) SPSKRKFSMEPGDED S28
VGLL4 iso4 (human) sPSKRKFSMEPGDED S65
VGLL4 (mouse) sPsKRKFsMEPGDKD S65-p
VGLL4 (rat) sPSKRKFSLEHGDKD S65
K76-ub
CDNDHVSkMSRIFNP
0 1
VGLL4 (human) CDNDHVSkMSRIFNP K76-ub
VGLL4 iso2 (human) CDNDHVSKMSRIFNP K45
VGLL4 iso4 (human) CDNDHVSKMSRIFNP K82
VGLL4 (mouse) CENDHVSKMSRIFSP K82
VGLL4 (rat) CENDHVSKMSRIFSP K82
K87-ub
IFNPHLNktANGDCR
0 1
VGLL4 (human) IFNPHLNktANGDCR K87-ub
VGLL4 iso2 (human) IFNPHLNKTANGDCR K56
VGLL4 iso4 (human) IFNPHLNKTANGDCR K93
VGLL4 (mouse) IFSPHLNKTVNGDCR K93
VGLL4 (rat) IFSPHLNKTVNGDCR K93
T88-p
FNPHLNktANGDCRR
0 2
VGLL4 (human) FNPHLNktANGDCRR T88-p
VGLL4 iso2 (human) FNPHLNKTANGDCRR T57
VGLL4 iso4 (human) FNPHLNKTANGDCRR T94
VGLL4 (mouse) FSPHLNKTVNGDCRR T94
VGLL4 (rat) FSPHLNKTVNGDCRR T94
S101-p
RRDPRERsRsPIERA
0 6
VGLL4 (human) RRDPRERsRsPIERA S101-p
VGLL4 iso2 (human) RRDPRERSRSPIERA S70
VGLL4 iso4 (human) RRDPRERSRSPIERA S107
VGLL4 (mouse) RRDPRERsRsPIERA S107-p
VGLL4 (rat) RRDPRERSRSPIERA S107
S103-p
DPRERsRsPIERAVA
0 6
VGLL4 (human) DPRERsRsPIERAVA S103-p
VGLL4 iso2 (human) DPRERSRSPIERAVA S72
VGLL4 iso4 (human) DPRERSRSPIERAVA S109
VGLL4 (mouse) DPRERsRsPIERAAA S109-p
VGLL4 (rat) DPRERSRSPIERAAA S109
T122-p
LHGSHLYtsLPSLGL
0 1
VGLL4 (human) LHGSHLYtsLPSLGL T122-p
VGLL4 iso2 (human) LHGSHLYTSLPSLGL T91
VGLL4 iso4 (human) LHGSHLYTSLPSLGL T128
VGLL4 (mouse) LHGGHLYASLPSLME A128
VGLL4 (rat) LHGGHLYASLPSLME A128
S123-p
HGSHLYtsLPSLGLE
0 3
VGLL4 (human) HGSHLYtsLPSLGLE S123-p
VGLL4 iso2 (human) HGSHLYTSLPSLGLE S92
VGLL4 iso4 (human) HGSHLYTSLPSLGLE S129
VGLL4 (mouse) HGGHLYASLPSLMEQ S129
VGLL4 (rat) HGGHLYASLPSLMEQ S129
S149-p
ASRPAGLsPtLtPGE
Upstream
1 23
Treatment
  • BI_4834
  • ischemia
  • nocodazole
view more >
VGLL4 (human) ASRPAGLsPtLtPGE S149-p
VGLL4 iso2 (human) ASRPAGLSPTLTPGE S118
VGLL4 iso4 (human) ASRPAGLsPTLtPGE S155-p
VGLL4 (mouse) gap -
VGLL4 (rat) gap -
T151-p
RPAGLsPtLtPGERQ
0 1
VGLL4 (human) RPAGLsPtLtPGERQ T151-p
VGLL4 iso2 (human) RPAGLSPTLTPGERQ T120
VGLL4 iso4 (human) RPAGLsPTLtPGERQ T157
VGLL4 (mouse) gap -
VGLL4 (rat) gap -
T153-p
AGLsPtLtPGERQQN
Upstream
1 7
Treatment
  • nocodazole
VGLL4 (human) AGLsPtLtPGERQQN T153-p
VGLL4 iso2 (human) AGLSPTLTPGERQQN T122
VGLL4 iso4 (human) AGLsPTLtPGERQQN T159-p
VGLL4 (mouse) gap -
VGLL4 (rat) gap -
S163-p
ERQQNRPsVITCASA
0 1
VGLL4 (human) ERQQNRPsVITCASA S163-p
VGLL4 iso2 (human) ERQQNRPSVITCASA S132
VGLL4 iso4 (human) ERQQNRPSVITCASA S169
VGLL4 (mouse) ERQQNRPSVITCASA S160
VGLL4 (rat) ERQQNRPSVITCASA S160
S200-p
ASYRRPPsAATTCDP
0 4
VGLL4 (human) ASYRRPPsAATTCDP S200-p
VGLL4 iso2 (human) ASYRRPPSAATTCDP S169
VGLL4 iso4 (human) ASYRRPPSAATTCDP S206
VGLL4 (mouse) ASYRRPPsATATCDP S197-p
VGLL4 (rat) ASYRRPPSATATCDP S197
K219
HFRRSLGKNYKEPEP
1 1
VGLL4 (human) HFRRSLGKNYKEPEP K219
VGLL4 iso2 (human) HFRRSLGKNYKEPEP K188
VGLL4 iso4 (human) HFRRSLGKNYKEPEP K225
VGLL4 (mouse) HFRRSLGkNYKEPEP K216-ac
VGLL4 (rat) HFRRSLGKNYKEPEP K216
G258
QIKAAKDGAsssPEs
0 1
VGLL4 (human) QIKAAKDGAsssPEs G258
VGLL4 iso2 (human) QIKAAKDGASSSPES G227
VGLL4 iso4 (human) QIKAAKDGASSSPES G264
VGLL4 (mouse) QIKAAKDsASssPES S255-p
VGLL4 (rat) QIKAAKDSASSsPES S255
S260-p
KAAKDGAsssPEsAs
0 1
VGLL4 (human) KAAKDGAsssPEsAs S260-p
VGLL4 iso2 (human) KAAKDGASSSPESAS S229
VGLL4 iso4 (human) KAAKDGASSSPESAS S266
VGLL4 (mouse) KAAKDsASssPESAS S257
VGLL4 (rat) KAAKDSASSsPESAS S257
S261-p
AAKDGAsssPEsAsR
0 4
VGLL4 (human) AAKDGAsssPEsAsR S261-p
VGLL4 iso2 (human) AAKDGASSSPESASR S230
VGLL4 iso4 (human) AAKDGASSSPESASR S267
VGLL4 (mouse) AAKDsASssPESASR S258-p
VGLL4 (rat) AAKDSASSsPESASR S258
S262-p
AKDGAsssPEsAsRR
0 11
VGLL4 (human) AKDGAsssPEsAsRR S262-p
VGLL4 iso2 (human) AKDGASSSPESASRR S231
VGLL4 iso4 (human) AKDGASSSPESASRR S268
VGLL4 (mouse) AKDsASssPESASRR S259-p
VGLL4 (rat) AKDSASSsPESASRR S259-p
S265-p
GAsssPEsAsRRGQP
0 1
VGLL4 (human) GAsssPEsAsRRGQP S265-p
VGLL4 iso2 (human) GASSSPESASRRGQP S234
VGLL4 iso4 (human) GASSSPESASRRGQP S271
VGLL4 (mouse) sASssPESASRRGQP S262
VGLL4 (rat) SASSsPESASRRGQP S262
S267-p
sssPEsAsRRGQPAs
0 1
VGLL4 (human) sssPEsAsRRGQPAs S267-p
VGLL4 iso2 (human) SSSPESASRRGQPAS S236
VGLL4 iso4 (human) SSSPESASRRGQPAs S273
VGLL4 (mouse) SssPESASRRGQPAs S264
VGLL4 (rat) SSsPESASRRGQPAS S264
S274-p
sRRGQPAsPsAHMVs
Upstream
1 66
Treatment
  • EGF
  • nocodazole
VGLL4 (human) sRRGQPAsPsAHMVs S274-p
VGLL4 iso2 (human) SRRGQPASPSAHMVS S243
VGLL4 iso4 (human) SRRGQPAsPSAHMVS S280-p
VGLL4 (mouse) SRRGQPAsPtAHMVs S271-p
VGLL4 (rat) SRRGQPASPTAHMVS S271
S276-p
RGQPAsPsAHMVsHs
0 19
VGLL4 (human) RGQPAsPsAHMVsHs S276-p
VGLL4 iso2 (human) RGQPASPSAHMVSHS S245
VGLL4 iso4 (human) RGQPAsPSAHMVSHS S282
VGLL4 (mouse) RGQPAsPtAHMVsHS T273-p
VGLL4 (rat) RGQPASPTAHMVSHS T273
S281-p
sPsAHMVsHsHsPsV
Upstream
0 3
Treatment
  • MLN8054
VGLL4 (human) sPsAHMVsHsHsPsV S281-p
VGLL4 iso2 (human) SPSAHMVSHSHSPSV S250
VGLL4 iso4 (human) sPSAHMVSHSHSPSV S287
VGLL4 (mouse) sPtAHMVsHSHsPSV S278-p
VGLL4 (rat) SPTAHMVSHSHSPSV S278
S283-p
sAHMVsHsHsPsVVs
0 6
VGLL4 (human) sAHMVsHsHsPsVVs S283-p
VGLL4 iso2 (human) SAHMVSHSHSPSVVS S252
VGLL4 iso4 (human) SAHMVSHSHSPSVVS S289
VGLL4 (mouse) tAHMVsHSHsPSVVS S280
VGLL4 (rat) TAHMVSHSHSPSVVS S280
S285-p
HMVsHsHsPsVVs__
Upstream
0 21
Treatment
  • MLN8054
VGLL4 (human) HMVsHsHsPsVVs__ S285-p
VGLL4 iso2 (human) HMVSHSHSPSVVS__ S254
VGLL4 iso4 (human) HMVSHSHSPSVVS__ S291
VGLL4 (mouse) HMVsHSHsPSVVS__ S282-p
VGLL4 (rat) HMVSHSHSPSVVS__ S282
S287-p
VsHsHsPsVVs____
0 7
VGLL4 (human) VsHsHsPsVVs____ S287-p
VGLL4 iso2 (human) VSHSHSPSVVS____ S256
VGLL4 iso4 (human) VSHSHSPSVVS____ S293
VGLL4 (mouse) VsHSHsPSVVS____ S284
VGLL4 (rat) VSHSHSPSVVS____ S284
S290-p
sHsPsVVs_______
0 5
VGLL4 (human) sHsPsVVs_______ S290-p
VGLL4 iso2 (human) SHSPSVVS_______ S259
VGLL4 iso4 (human) SHSPSVVS_______ S296
VGLL4 (mouse) SHsPSVVS_______ S287
VGLL4 (rat) SHSPSVVS_______ S287